Trials / Completed
CompletedNCT01742000
Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women
Double-blinded Placebo-controlled Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Institute for Atherosclerosis Research, Russia · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the anti-atherosclerotic action of natural drug Karinat based on phytoestrogen-rich botanicals in postmenopausal women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Karinat | |
| DRUG | Placebo | Sugar pill manufactured to mimic Karinat 500 mg tablet |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2012-06-01
- Completion
- 2012-10-01
- First posted
- 2012-12-05
- Last updated
- 2012-12-06
Source: ClinicalTrials.gov record NCT01742000. Inclusion in this directory is not an endorsement.